• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.23% Nasdaq Up1.74%

    Repros Therapeutics Inc. (RPRX)

    7.76 Up 0.49(6.74%) Oct 2, 4:00PM EDT
    ProfileGet Profile for:
    Repros Therapeutics Inc.
    2408 Timberloch Place
    Suite B-7
    The Woodlands, TX 77380
    United States - Map
    Phone: 281-719-3400
    Fax: 281-719-3446
    Website: http://www.reprosrx.com

    Index Membership:N/A
    Full Time Employees:26

    Business Summary 

    Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders for male and female in the United States. Its product portfolio includes Androxal, an oral therapy, which is in Phase III clinical trials for the treatment of low testosterone due to secondary hypogonadism; and Proellex that is in Phase IIB clinical trials for the treatment of symptoms associated with uterine fibroids, as well as in Phase II clinical trial for the treatment of endometriosis. The company has a license agreement with the National Institutes of Health to develop and commercialize Proellex. Repros Therapeutics Inc. was founded in 1987 and is based in The Woodlands, Texas.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Repros Therapeutics Inc.

    Corporate Governance 
    Repros Therapeutics Inc.’s ISS Governance QuickScore as of Jul 1, 2015 is 7. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 7; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Joseph S. Podolski , 68
    Chief Exec. Officer, Pres and Director
    Ms. Katherine A. Anderson CPA, 57
    Chief Financial Officer, Chief Accounting Officer and Sec.
    Dr. Jaye L. Thompson Ph.D., 49
    Sr. VP of Clinical & Regulatory
    Dr. Joachim F. Wernicke M.D., Ph.D., 67
    Chief Medical Officer
    Dr. Ronald Wiehle Ph.D., DSC, 66
    VP of R&D
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders